Researchers reviewed records of nearly a million diabetic patients and found a 40% to 70% lower rate of first Alzheimer's diagnosis. Lead author Rong Xu says it's a link, not proof. Story dates from 2024.
Recap by typeshit. Full story at Yahoo.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Robert Lufkin MD shares the observational data: an average 16.1 kg lost at six months among 7,297 women, with 62.7% reporting side effects.
In Malayalam, the endocrinologist argues that treating the drugs as a quick fix raises the chance of side effects, and that better health should be the main goal.
A report on a federal effort putting drugs like Wegovy and Zepbound within reach for qualifying Medicare enrollees. Tap through for who qualifies.
Loading…